January 30, 2017 – Renishaw is pleased to announce that a neuromate® stereotactic robot system and neuroinspire™ surgical planning software have been installed and used at Alder Hey Children's Hospital, Liverpool. Not only is this hospital a Centre of Excellence for cancer, spinal, heart and brain conditions but it is also one of the four national centres for childhood epilepsy surgery (CESS) – a joint service with Royal Manchester Children's Hospital.
The first procedure carried out using the neuromate stereotactic robot and neuroinspire planning software was a stereoelectroencephalography (SEEG) case for epilepsy, under the management of consultant neurosurgeons, Miss Sasha Burn and Dr. Anand Ayer. After the success of their first case, the team are already planning their next SEEG procedure.
Dr Abed Hammoud, CEO of Renishaw Mayfield SA (Switzerland) said, “We are excited about the partnership with Alder Hey Children's Hospital. Our team will continue supporting this leading centre in providing excellent patient care using Renishaw's neurosurgical solutions”.
Ad Statistics
Times Displayed: 6679
Times Visited: 20 Brand-New FDA-cleared Advanced Ultrasound Medical Device available for sale or lease to Wound Care Centers or any other Medical Facilities.The Arobella 1000D is designed for non-contact or debridement ultrasound wound healing therapy, or any other wounds
Please visit www.renishaw.com/neuro for further information on our neurological products and therapies.
About Renishaw
Renishaw is one of the world's leading engineering and scientific technology companies, with expertise in precision measurement and healthcare. The company supplies products and services used in applications as diverse as jet engine and wind turbine manufacture, through to dentistry and brain surgery. It is also a world leader in the field of additive manufacturing (also referred to as 3D printing), where it is the only UK business that designs and makes industrial machines which ‘print' parts from metal powder.
The Renishaw Group currently has more than 70 offices in 35 countries, with over 4,000 employees, of which 2,800 people are employed within the UK. The majority of the company's R&D and manufacturing is carried out in the UK and for the year ended June 2016 Renishaw achieved sales of £436.6 million of which 95% was due to exports. The company's largest markets are China, USA, Germany and Japan.
The Company’s success has been recognised with numerous international awards, including eighteen Queen’s Awards recognising achievements in technology, export and innovation.
